Cargando…

Healthcare resource use in schizophrenia, EuroSC findings

Background: It is unclear if the burden associated with schizophrenia is affected by the type and severity of patient’s symptoms. Objective: This study aims to quantify healthcare resource use associated with different profiles of schizophrenia symptoms. Study design: Post-hoc analysis of data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Millier, A., Horváth, M., Ma, F., Kóczián, K., Götze, A., Toumi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645906/
https://www.ncbi.nlm.nih.gov/pubmed/29081923
http://dx.doi.org/10.1080/20016689.2017.1372027
_version_ 1783271978835116032
author Millier, A.
Horváth, M.
Ma, F.
Kóczián, K.
Götze, A.
Toumi, M.
author_facet Millier, A.
Horváth, M.
Ma, F.
Kóczián, K.
Götze, A.
Toumi, M.
author_sort Millier, A.
collection PubMed
description Background: It is unclear if the burden associated with schizophrenia is affected by the type and severity of patient’s symptoms. Objective: This study aims to quantify healthcare resource use associated with different profiles of schizophrenia symptoms. Study design: Post-hoc analysis of data from a naturalistic follow-up study. Setting: Secondary psychiatric services in France, Germany and the UK. Patients: EuroSC cohort:, representative sample of 1,208 schizophrenia patients Main outcome measure: We classified patients into eight health states, according to the Lenert classification (HS1–HS8), and estimated 6-month healthcare resource use (outpatient and day clinic visits, and hospitalisations) across the health states. Results: Approximately half of the patients were classed as having mild symptoms (HS1), with around 20% experiencing moderate, predominantly negative symptoms (HS2). The remaining health states were represented by <10% of patients each. Very few patients experienced extremely severe symptoms (HS8). No health state was associated with excess utilisation across all resource types. In terms of outpatient visits, patients were estimated to see a psychiatrist most often (3.01–4.15 visits over 6 months). Hospital admission was needed in 11%(HS1) – 35%(HS8) of patients and inpatient stays were generally prolonged for all health states (39–57 days). The average number of inpatient days was highest for patients in HS8 (18.17 days), followed by patients with severe negative symptoms (HS4; 13.37 days). In other health states characterised by severe symptoms (HS5–HS7), the average number of inpatient days was approximately half of those seen for HS4 (6.09–7.66). Conclusion: While none of the symptom profiles was associated with excess resource usage, hospitalization days were highest for HS with severe, predominantly negative or extremely severe symptoms. Patients with predominantly negative, moderate or severe symptoms appeared to have a high number of psychologist visits – an interesting finding that may reflect a specific therapeutic approach to the treatment of these patients.
format Online
Article
Text
id pubmed-5645906
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Routledge
record_format MEDLINE/PubMed
spelling pubmed-56459062017-10-27 Healthcare resource use in schizophrenia, EuroSC findings Millier, A. Horváth, M. Ma, F. Kóczián, K. Götze, A. Toumi, M. J Mark Access Health Policy Article Background: It is unclear if the burden associated with schizophrenia is affected by the type and severity of patient’s symptoms. Objective: This study aims to quantify healthcare resource use associated with different profiles of schizophrenia symptoms. Study design: Post-hoc analysis of data from a naturalistic follow-up study. Setting: Secondary psychiatric services in France, Germany and the UK. Patients: EuroSC cohort:, representative sample of 1,208 schizophrenia patients Main outcome measure: We classified patients into eight health states, according to the Lenert classification (HS1–HS8), and estimated 6-month healthcare resource use (outpatient and day clinic visits, and hospitalisations) across the health states. Results: Approximately half of the patients were classed as having mild symptoms (HS1), with around 20% experiencing moderate, predominantly negative symptoms (HS2). The remaining health states were represented by <10% of patients each. Very few patients experienced extremely severe symptoms (HS8). No health state was associated with excess utilisation across all resource types. In terms of outpatient visits, patients were estimated to see a psychiatrist most often (3.01–4.15 visits over 6 months). Hospital admission was needed in 11%(HS1) – 35%(HS8) of patients and inpatient stays were generally prolonged for all health states (39–57 days). The average number of inpatient days was highest for patients in HS8 (18.17 days), followed by patients with severe negative symptoms (HS4; 13.37 days). In other health states characterised by severe symptoms (HS5–HS7), the average number of inpatient days was approximately half of those seen for HS4 (6.09–7.66). Conclusion: While none of the symptom profiles was associated with excess resource usage, hospitalization days were highest for HS with severe, predominantly negative or extremely severe symptoms. Patients with predominantly negative, moderate or severe symptoms appeared to have a high number of psychologist visits – an interesting finding that may reflect a specific therapeutic approach to the treatment of these patients. Routledge 2017-09-05 /pmc/articles/PMC5645906/ /pubmed/29081923 http://dx.doi.org/10.1080/20016689.2017.1372027 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Millier, A.
Horváth, M.
Ma, F.
Kóczián, K.
Götze, A.
Toumi, M.
Healthcare resource use in schizophrenia, EuroSC findings
title Healthcare resource use in schizophrenia, EuroSC findings
title_full Healthcare resource use in schizophrenia, EuroSC findings
title_fullStr Healthcare resource use in schizophrenia, EuroSC findings
title_full_unstemmed Healthcare resource use in schizophrenia, EuroSC findings
title_short Healthcare resource use in schizophrenia, EuroSC findings
title_sort healthcare resource use in schizophrenia, eurosc findings
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645906/
https://www.ncbi.nlm.nih.gov/pubmed/29081923
http://dx.doi.org/10.1080/20016689.2017.1372027
work_keys_str_mv AT milliera healthcareresourceuseinschizophreniaeuroscfindings
AT horvathm healthcareresourceuseinschizophreniaeuroscfindings
AT maf healthcareresourceuseinschizophreniaeuroscfindings
AT kocziank healthcareresourceuseinschizophreniaeuroscfindings
AT gotzea healthcareresourceuseinschizophreniaeuroscfindings
AT toumim healthcareresourceuseinschizophreniaeuroscfindings